Listed

Celldex Therapeutics, Inc.: Form 10-Q for the period ended Jun 30, 2021

Filed with the SEC on Aug 5, 2021 and accepted by EDGAR at Aug 5, 2021, 16:07 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-04-01 to 2021-06-30$3.5mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2021-01-01 to 2021-06-30$4.2mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Research and development3 months2021-04-01 to 2021-06-30$12.4mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2021-01-01 to 2021-06-30$25.1mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2021-04-01 to 2021-06-30−$13.4mus-gaap:OperatingIncomeLoss
Operating income6 months2021-01-01 to 2021-06-30−$30.1mus-gaap:OperatingIncomeLoss
Net income3 months2021-04-01 to 2021-06-30−$13.4mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Net income6 months2021-01-01 to 2021-06-30−$29.9mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Operating cash flow6 months2021-01-01 to 2021-06-30−$30.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2021-01-01 to 2021-06-30$710.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2021-06-30$43.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-06-30$167.6mus-gaap:AssetsCurrent
Total assetsAt period end2021-06-30$204.6mus-gaap:Assets
Current liabilitiesAt period end2021-06-30$14.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-06-30$22.3mus-gaap:Liabilities
Shareholders' equityAt period end2021-06-30$182.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001104659-21-100745. Last ingested by Listed: Nov 5, 2026, 19:04 ET. Listed shows no prices and gives no investment advice.